13F
中

BHC BAUSCH HEALTH COS INC

2026Q1 · CUSIP 071734107 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
224
Δ holders QoQ
-10
Breadth percentile
Top 86%
Whale holders
113
Δ whales
-1
Inst. holding value
$1.3B
New positions
29
Closed positions
39
Price momentum (1Q)
-10.9%
Put / Call
10/10

Breadth history (34 quarters)

2018Q3: Δ+310 · h=328 2018Q4: Δ+2 · h=330 2019Q1: Δ+16 · h=346 2019Q2: Δ-14 · h=332 2019Q3: Δ-18 · h=314 2019Q4: Δ+10 · h=324 2020Q1: Δ-19 · h=305 2020Q2: Δ-4 · h=301 2020Q3: Δ+16 · h=317 2020Q4: Δ+19 · h=336 2021Q1: Δ+11 · h=347 2021Q2: Δ+10 · h=357 2021Q3: Δ-13 · h=344 2021Q4: Δ+33 · h=377 2022Q1: Δ-10 · h=367 2022Q2: Δ-41 · h=326 2022Q3: Δ-44 · h=282 2022Q4: Δ-20 · h=262 2023Q1: Δ-28 · h=234 2023Q2: Δ-2 · h=232 2023Q3: Δ-10 · h=222 2023Q4: Δ+13 · h=235 2024Q1: Δ-1 · h=234 2024Q2: Δ+0 · h=234 2024Q3: Δ-25 · h=209 2024Q4: Δ+17 · h=226 2025Q1: Δ+2 · h=228 2025Q2: Δ-19 · h=209 2025Q3: Δ+8 · h=217 2025Q4: Δ+17 · h=234 2026Q1: Δ-10 · h=224 2018Q3: holders=328 2018Q4: holders=330 2019Q1: holders=346 2019Q2: holders=332 2019Q3: holders=314 2019Q4: holders=324 2020Q1: holders=305 2020Q2: holders=301 2020Q3: holders=317 2020Q4: holders=336 2021Q1: holders=347 2021Q2: holders=357 2021Q3: holders=344 2021Q4: holders=377 2022Q1: holders=367 2022Q2: holders=326 2022Q3: holders=282 2022Q4: holders=262 2023Q1: holders=234 2023Q2: holders=232 2023Q3: holders=222 2023Q4: holders=235 2024Q1: holders=234 2024Q2: holders=234 2024Q3: holders=209 2024Q4: holders=226 2025Q1: holders=228 2025Q2: holders=209 2025Q3: holders=217 2025Q4: holders=234 2026Q1: holders=224 -310 -155 +0 +155 +310 188292396 18Q319Q220Q120Q421Q322Q223Q123Q424Q325Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2021Q4 Top 15% -60.9% -77.4%
2020Q3 Top 16% +58.5% +51.9%
2019Q1 Top 18% -15.0% +10.7%
2018Q3 Top 0% -7.2% -3.5%

Options Sentiment

Put holders
10
QoQ: -1
Call holders
10
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-3.24
EPS YoY
—
Revenue (TTM)
$10.5B
Revenue YoY
+8.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $2.0B 2022-09-30: $2.0B 2022-12-31: $2.2B 2023-03-31: $1.9B 2023-06-30: $2.2B 2023-09-30: $2.2B 2023-12-31: $2.4B 2024-03-31: $2.2B 2024-06-30: $2.4B 2024-09-30: $2.5B 2024-12-31: $2.6B 2025-03-31: $2.3B 2025-06-30: $2.5B 2025-09-30: $2.7B 2025-12-31: $2.8B 2026-03-31: $2.5B 2022-06-30: EPS -0.40 2022-09-30: EPS 1.10 2022-12-31: EPS -1.13 2023-03-31: EPS -0.55 2023-06-30: EPS 0.07 2023-09-30: EPS -1.03 2023-12-31: EPS -0.11 2024-03-31: EPS -0.17 2024-06-30: EPS 0.03 2024-09-30: EPS -0.23 2024-12-31: EPS 0.24 2025-03-31: EPS -0.16 2025-06-30: EPS 0.40 2025-09-30: EPS 0.48 2025-12-31: EPS -0.30 2026-03-31: EPS -3.82 0B 1.4B 2.8B $B -4.20 -1.50 1.21 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 14 2025-06-30: PE 33.42025-09-30: PE 6.52025-12-31: PE 14.3 6 20 35 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)